Several randomized clinical trials have demonstrated that mechanical thrombectomy (MT) combined with intravenous administration of tissue plasminogen activator (tPA) for patients in the early stage of acute ischemic stroke can result in better outcomes 90 days after the stroke, lower mortality rates, lower frequency of hemorrhagic complications, and an improved revascularization rate [1–5]. Here, PLAT is linked to Stroke.